Alterations of Plasma Galectin-3 and C3 Levels in Patients with Parkinson’s Disease
Parkinson’s disease (PD) is characterized by progressive neurodegeneration of dopaminergic neurons in the ventral midbrain. The complement-phagosome pathway is involved in the pathogenesis of PD. Here we measured levels of complement-phagocytosis molecules, including galectin-3, C3, C4, and cathepsi...
Guardado en:
Autores principales: | Hsiu-Chuan Wu, Kuo-Hsuan Chang, Mu-Chun Chiang, Chiung-Mei Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3c805b253b234da5ba17f579a322b431 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Does Diabetes Alter Immunolocalization of Galectin-1 and Galectin-3 in the Rat Ovary?
por: Özdenoglu,Berna, et al.
Publicado: (2016) -
Galectina-3: experiencia en pacientes chilenos con diagnóstico de insuficiencia cardíaca descompensada
por: Rossel,Víctor, et al.
Publicado: (2017) -
Galectin-3 Inhibits Galectin-8/Parkin-Mediated Ubiquitination of Group A Streptococcus
por: Yi-Lin Cheng, et al.
Publicado: (2017) -
Novel Galectin-3 Roles in Neurogenesis, Inflammation and Neurological Diseases
por: Luana C. Soares, et al.
Publicado: (2021) -
Diminished Expression of Galectin-3 Around Blisters in Bullous Pemphigoid: An Immunohistochemistry Study
por: Maryam Aghighi, et al.
Publicado: (2020)